SIGNIFICANCE OF HAPLOTYPE B DONORS AND GENE CONTENT MOTIFS IN NONMYELOABLATIVE, HLA-HAPLOIDENTICAL (Haplo) BMT WITH POSTTRANSPLANTATION HIGH-DOSE CYCLOPHOSPHAMIDE (PT/Cy)

被引：2
|
作者：
Symons, H. J. [1 ]
Munchel, A. T. [1 ]
Rossiter, N. L. [1 ]
Kasamon, Y. L. [1 ]
Jones, R. J. [1 ]
Fuchs, E. J. [1 ]
Leffell, M. S. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
41
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 20 条
  • [1] Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy)
    Kasamon, Yvette L.
    Luznik, Leo
    Leffell, M. Sue
    Tsai, Hua-ling
    Symons, Heather J.
    Bolanos-Meade, Javier
    Rosner, Gary
    Morris, Lawrence E.
    Crilley, Pamela A.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. BLOOD, 2011, 118 (21) : 383 - 384
  • [2] Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
    McCurdy, Shannon R.
    Kanakry, Jennifer A.
    Showel, Margaret M.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Rosner, Gary L.
    Kanakry, Christopher G.
    Perica, Karlo
    Symons, Heather J.
    Brodsky, Robert A.
    Gladstone, Douglas E.
    Huff, Carol Ann
    Pratz, Keith W.
    Prince, Gabrielle T.
    Dezern, Amy E.
    Gojo, Ivana
    Matsui, William H.
    Borrello, Ivan
    McDevitt, Michael A.
    Swinnen, Lode J.
    Smith, B. Douglas
    Levis, Mark J.
    Ambinder, Richard F.
    Luznik, Leo
    Jones, Richard J.
    Fuchs, Ephraim J.
    Kasamon, Yvette L.
    [J]. BLOOD, 2015, 125 (19) : 3024 - 3031
  • [3] NONMYELOABLATIVE HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION (HAPLO-BMT) WITH POST-TRANSPLANT HIGH-DOSE CYCLOPHOSPHAMIDE (CY) IN PATIENTS WITH SEVERE HEMOGLOBINOPATHIES
    Bolanos-Meade, J.
    Lanzkron, S.
    Kemberling, H.
    Gamper, C.
    Ambinder, R. F.
    Luznik, L.
    Luznik, E. J.
    Jones, R. J.
    Brodsky, R. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S285 - S285
  • [4] Nonmyeloablative HLA-Haploidentical (NMA Haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Is Associated with Similar Outcomes to Matched BMT When Stratified By Disease Risk Index (DRI)
    McCurdy, Shannon R.
    Kanakry, Jennifer A.
    Showel, Margaret M.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Kanakry, Christopher G.
    Gladstone, Douglas E.
    Luznik, Leo
    Huff, Carol Ann
    Swinnen, Lode J.
    Ambinder, Richard F.
    Jones, Richard J.
    Fuchs, Ephraim J.
    Kasamon, Yvette L.
    [J]. BLOOD, 2014, 124 (21)
  • [5] Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction
    Kasamon, Yvette L.
    Fuchs, Ephraim J.
    Zahurak, Marianna
    Rosner, Gary L.
    Symons, Heather J.
    Bolanos-Meade, Javier
    Jones, Richard J.
    [J]. BLOOD, 2016, 128 (22)
  • [6] Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
    Kasamon, Yvette L.
    Luznik, Leo
    Leffell, Mary S.
    Kowalski, Jeanne
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Morris, Lawrence E.
    Crilley, Pamela A.
    O'Donnell, Paul V.
    Rossiter, Nancy
    Huff, Carol Ann
    Brodsky, Robert A.
    Matsui, William H.
    Swinnen, Lode J.
    Borrello, Ivan
    Powell, Jonathan D.
    Ambinder, Richard F.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (04) : 482 - 489
  • [7] HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
    Luznik, Leo
    O'Donnell, Paul V.
    Symons, Heather J.
    Chen, Allen R.
    Leffell, M. Susan
    Zahurak, Marianna
    Gooley, Ted A.
    Piantadosi, Steve
    Kaup, Michele
    Ambinder, Richard F.
    Huff, Carol Ann
    Matsui, William
    Bolanos-Meade, Javier
    Borrello, Ivan
    Powell, Jonathan D.
    Harrington, Elizabeth
    Warnock, Sandy
    Flowers, May
    Brodsky, Robert A.
    Sandmaier, Brenda M.
    Storb, Rainer F.
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 641 - 650
  • [8] Outcomes Of Nonmyeloablative (NMA) Haploidentical Blood Or Marrow Transplantation (haploBMT) With High-Dose Posttransplantation Cyclophosphamide (PT/Cy) For Lymphoma
    Kasamon, Yvette L.
    Bolanos-Meade, Javier
    Gladstone, Douglas
    Swinnen, Lode J.
    Kanakry, Jennifer A.
    Tsai, Hua-Ling
    Luznik, Leo
    Fuchs, Ephraim J.
    Jones, Richard J.
    Ambinder, Richard F.
    [J]. BLOOD, 2013, 122 (21)
  • [9] Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
    Kasamon, Yvette L.
    Ambinder, Richard F.
    Fuchs, Ephraim J.
    Zahurak, Marianna
    Rosner, Gary L.
    Bolanos-Meade, Javier
    Levis, Mark J.
    Gladstone, Douglas E.
    Huff, Carol Ann
    Swinnen, Lode J.
    Matsui, William H.
    Borrello, Ivan
    Brodsky, Robert A.
    Jones, Richard J.
    Luznik, Leo
    [J]. BLOOD ADVANCES, 2017, 1 (04) : 288 - 292
  • [10] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
12